explore -WSS

explore

author：fashion 2025-09-30 18:00:31 - browse：8

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Health insurers' Q3 question: how much care are people getting?

WSS

Setback for rare diseases as Taysha Gene Therapies pulls back

What we owe ALS patients — and why one company fell short

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

A new nitrogen execution bill also undermines medical licensing

2023 Nobel Prize in Medicine goes to Karikó and Weissman

PBM reform efforts get punted in Congress

explore

explore

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

Obesity drugs seen as possible treatment for liver disease MASH

After affirmative action ruling, medical educators look to 'holistic review'

New oral drug delivery patch is modeled after octopus tentacles

Medicare details structure of new drug price negotiation program

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

United colonoscopy coverage change 'may cost lives,' doctors say

Flu, Covid vaccination rates decline, new survey data show

Medicare proposal to cover medical devices draws a mixed reaction

Nobel honors Karikó and Weissman's enduring partnership

Wikipedia

Will an HIV vaccine ever be a reality?

New documents shed light on MD Anderson Cancer Institute feud

What will Novo Nordisk's VC do with its influx of cash?

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Stop Congress from blocking public access to science

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

focus

hotspot

hotspot

Wikipedia